5%) risk of outcome, hs-cTnT >50 ng/L were associated with a 29% (95CI: 26-33%) risk of outcome. NT-pro BNP level 125 ng/L were associated with a 4% (95CI: 4-5%) risk of outcome, NT-pro BNP >2000 ng/L were associated with a 29% (95CI: 25-32%) risk of outcome. Likelihood ratios and predictive values showed similar results for both biomarkers (Table) . Associations did not change significantly when we excluded patients who had a serious outcome found during the ED index visit.
Study Objectives: Direct oral anticoagulants (OAC) are easier to use and have a lower incidence of intracranial hemorrhage than warfarin. Since their arrival, direct OACs have moderately increased overall prescribing of OACs by outpatient physicians for patients with nonvalvular atrial fibrillation and flutter (AFF) at high risk for stroke. Whether patterns are similar for emergency department (ED) physicians is unknown. We evaluated overall rates of OAC initiation at ED discharge among stroke-prone AFF patients following FDA approval of 3 direct OACs (dabigatran 10/2010; rivaroxaban 11/2011; apixaban 12/2012) . In this integrated health care delivery system, only dabigatran was added to the formulary (01/2014), after which both warfarin and dabigatran were recommended for nonvalvular AFF. We hypothesized that overall OAC prescribing would increase, not after FDA approval, but after formulary addition of dabigatran, and that warfarin would be preferred over direct OACs in higher-risk patients as in other practices.
Methods: We examined all adult members with a primary diagnosis of nonvalvular AFF and a high-risk stroke score (ATRIA 7; range 0-15) not on recent OACs (<90d) who were discharged from 21 community EDs from 01/2010 to 12/2017 in Kaiser Permanente Northern California. ATRIA is a validated stroke risk score that outperforms CHA 2 DS 2 -VASc. Eligibility criteria, including presence of OAC contraindications, were assessed at each patient encounter to capture all eligible encounters. We calculated annual rates of OAC initiation among all eligible ED discharge encounters. We compared mean ATRIA scores between recipients of warfarin and direct OAC in 2016-2017 in a mixed model accounting for multiple encounters per patient.
Results: Among 4,114 eligible ED encounters involving AFF, median age was 80 years (IQR 76-86) and 67.1% were women. FDA approval of direct OACs had minimal impact on prescribing: annual rates of OAC initiation varied little from 2010 through 2013 (Figure) , with warfarin predominating (99.1%). Following formulary addition in 2014, dabigatran initiation rates rose annually, surpassing warfarin in 2017 (dabigatran, 14.4%; warfarin, 9.2%; apixaban, 0.7%; rivaroxaban, 0.2%) and more than doubled the annual rate of overall OAC initiation from 2014 to 2017: 9.7% to 24.4% (P<0.0001; Figure) . In 2016-2017, mean ATRIA scores at the prescribing encounter were similar between warfarin recipients (12.6; n¼45) and direct OAC recipients (12.0; n¼68; P¼0.07).
Conclusions: Rates of overall OAC initiation at ED discharge for nonvalvular AFF patients at high risk for stroke increased subsequent to inclusion of dabigatran on the formulary. Warfarin use was not significantly more prevalent in higher-risk patients, though the sample sizes were small. Opportunities remain to expand prescribing of OACs for ED AFF patients at high risk for thromboembolism and to develop personalized approaches to optimize stroke prevention strategies. Study Objectives: Sex differences in language for letters of recommendation have been identified in many professional fields. Our prior study evaluated the narrative portion of the emergency medicine Standardized Letter of Evaluation (SLOE) for all applicants invited to interview during a single residency application cycle. In this prior study, we found that letters of recommendation for women applicants had more frequent words related to "affiliation," and contrary to prior research, "ability" words appeared with greater frequency for women applicants. We now aim to examine the differences in language used to describe men and women applicants within the SLOE narrative for all applicants in one application cycle, rather than only the invited applicants.
Sex Differences in Language of Standardized Letter of Evaluation Narrative for Emergency Medicine Residency Applicants
Methods: All applicants to a 4-year urban, academic EM residency program within a single application year were included in the sample. Only SLOEs from the applicants' first EM rotation were included. Exclusion criteria were: SLOE of applicants from nonLiaison Committee on Medical Education (LCME) schools or first rotation SLOE not available for download. Data was collected on applicant sex, age, Alpha Omega Alpha (AOA) designation, and medical school rank. The previously validated Linguistic Inquiry and Word Count (LIWC) program was used to analyze frequency of words within categories relevant to letters of recommendation. We assessed for differences by sex in 16 word categories (9 defined by the LIWC and 7 defined by word lists created by previous studies in the field). Descriptive statistics, chi-squared and t-tests were used to describe the sample, and Mann-Whitney U tests were used to compare the word counts by sex.
Results: Of 1001 applicants in the 2016 application cycle to our institution, 822 (82%) had a first rotation SLOE available for analysis. 64% were men and 36% were women; there were no differences between sex for baseline characteristics including: age (mean 27 years), top 25 schools (22.5%), AOA rates (12.7%), and having earned advanced degrees (10%). The median word count per SLOE narrative for men was 170 and for women was 180, which was not statistically different (p¼0.15). Within the 16 word categories, after adjusting for letter length, word frequency differences between sex were only present in 2 categories: social words (women: 23 words/letter; men: 21 words/letter, p¼0.05) and ability words (women: 2 words/letter; men: 1 word/letter, 
